Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 5, 2009, Pages 948-958

  Hooker, David J ^a   Gorry, Paul R ^a,b,c   Ellett, Anne M ^a   Wesselingh, Steven L ^a,c,d   Cherry, Catherine L ^a,c,d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

Antiretroviral drugs; Apoptosis; HAART; HIV 1; Ligation mediated polymerase chain reaction; Lipoatrophy; LM PCR; NRTI; Quantitation

Indexed keywords

CASPASE 3; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAUROSPORINE; STAVUDINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CASPASE 3; CELLS, CULTURED; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPODYSTROPHY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; STAUROSPORINE; STAVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67249153037     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00612.x     Document Type: Article

References (47)

1. Vaux DL, Korsemeyer SJ. Cell death in development. Cell. 1999 96 : 245 54.
2. Burns TF, El-Deiry W. Cell death signalling in malignancy. Cancer Treat Res. 2003 115 : 319 43.
3. Daniel PT, Weider T, Sturm I, Schulze-Osthoff K. The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia. 2001 15 : 1022 32.
4. Ozoren N, El-Deiry W. Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol. 2003 13 : 135 47.
5. Sheikh MS, Huang Y. Death receptors as targets of cancer therapeutics. Curr Drug Targets. 2004 4 : 97 104. (Pubitemid 38332568)
6. Thompson CB. Apoptosis in the pathogen-esis and treatment of disease. Science. 1995 267 : 1456 62.
7. Zörnig M, Hueber A, Baum W, Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta. 2001 1551 : F1 37.
8. Green DR, Evan G. A matter of life and death. Cancer Cell. 2002 1 : 19 30. (Pubitemid 41039172)
9. Khosravi-Far R, Degli Esposti M. Death receptor signals to mitochondria. Cancer Biol Ther. 2004 3 : 1051 7.
10. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT, Wang X. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA. 1998 95 : 8461 6.
11. Kerr JFR, Harmen BV. Definition and incidence of apoptosis, an historical perspective. In : Tomei LD, Cope FO, editors. Apoptosis: the molecular basis of cell death. New York : Cold Spring Harbor Laboratory Press 1991. pp. 5 29.
12. Kerr JFR, Searle J, Harmen BV, Bishop CJ. Apoptosis. In : Potten CS, editor. Perspectives on mammalian cell death. Oxford : Oxford University Press 1987. pp. 93 128.
13. Martz E, Howell DM. CTL: virus controls cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. Immunol Today. 1989 10 : 79 86. (Pubitemid 19087462)
14. Shi Y, Szalay MG, Paskar L, Boyer M, Sigh B, Green DR. Activation-induced cell death in T cell hybridomas is due to apoptosis. J Immunol. 1990 144 : 3326 33.
15. Staley K, Blaschke AJ, Chun J. Apoptotic DNA fragmentation is detected by a semi-quantitative ligation-mediated PCR of blunt DNA ends. Cell Death Differ. 1997 4 : 66 75.
16. Tian Q, Streuti M, Siato H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell. 1991 67 : 629 39.
17. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984 142 : 67 77. (Pubitemid 14151197)
18. Mueller PR, Wold B. In vivo footprinting of a muscle specific enhancer by ligation-mediated PCR. Science. 1989 246 : 780 6.
19. Mallal S, John M, Moore C, James I, McKinnon E. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000 14 : 1309 16.
20. Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A, Hirschel B, Boggian K, Chave JP, Opravil M, Weber R, Rickenbach M, Telenti A. Abnormalities of body fat distribution in HIV-infected persons treated with anti-retroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2002 31 : 50 5.
21. Cherry CL, McArthur JC, Hoy JF, Wesselingh SL. Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol. 26 2003 : 195 207. (Pubitemid 36206604)
22. Caron M, Auclair M, Lagathu C, Lombes A, Walker UA, Kornprobst M, Capeau J. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS. 2004 18 : 2127 36.
23. Cherry CL, Lal L, Thompson KA, McLean CA, Ross LL, Hernandez J, Wesselingh SL, McComsey G. Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching therapy from stavudine to abacavir or zidovudine. J Acquir Immune Defic Syndr. 2005 38 : 263 7.
24. Martin JL, Brown CE, Matthews-Davis N, Reardon JE. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother. 1994 38 : 2743 9.
25. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen C. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med. 1992 175 : 331 40.
26. Yue FY, Kovacs CM, Dimayuga RC, Gu XXJ, Parks P, Kaul R, Ostrowski MA. Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol. 2005 174 : 2196 204.
27. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 2005 12 : 878 92.
28. Sambrook J, Russell DW. Molecular cloning, a laboratory manual. 3rd ed. Cold Spring Harbor, New York : Cold Spring Harbor Laboratory Press 2001.
29. Zhang L, Lewin SR, Markowitz M, Lin H-H, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S, Vesanen M, Spiegel H, Kost R, Lunzen J, Stellbrink H-J, Wolinsky S, Borkowsky W, Palumbo P, Kostrikis LG, Ho DD. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med. 1999 190 : 725 32.
30. Olkkonen V, Gottleib M, Strassman PJ, Qiao X, Bamford DH, Mindich L. In vitro assembly of infectious nucleocapsids of bacteriophage 6: formation of a recombinant double-stranded RNA virus. Proc Natl Acad Sci USA. 1990 87 : 9173 7.
31. Stepczynska A, Lauber K, Engels IH, Janssen 0, Kabelitz D, Wesselborg S Schulz-Osthoff K. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene. 2001 20 : 1193 202.
32. Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 1994 54 : 1707 14.
33. Nakadate T, Jeng AY, Blumberg PM. Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem Pharmacol. 1988 37 : 1541 2.
34. Widlak P, Li P, Wang X, Garrard WT. Cleavage preferences of the apoptotic endonuclease DFF40 (caspase activated DNase or nuclease) on naked DNA and chromatin substrates. J Biol Chem. 2000 275 : 8226 32.
35. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 119 : 493 501.
36. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Technical tips. Trends genet. 1994 10 : 41 2.
37. Nicholson DW, Ali A, Thornberry NA, Vaillancourt J P, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK. Identification and inhibition of the ICE-CED-3 protease necessary for mammalian apoptosis. Nature. 1995 376 : 37 43.
38. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996 10 : 587 97.
39. McComsey G, Maa J-F. Host factors may be more important than choice of anti-retrovirals in the development of lipoatro-phy. AIDS Reader. 2003 13 : 539 42.
40. Masny A, Plucienniczak A. Ligation-mediated PCR performed at low denaturation temperatures - PCR melting profiles. Nuc Acids Res. 2003 31 : e114.
41. Guilfoyle RA, Leeck CL, Kroening D, Smith LM, Guo Z. Ligation-mediated PCR amplification of specific fragments from a class-II restriction endonuclease total digest. Nuc Acids Res. 1997 25 : 1854 58.
42. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsuni Y. Apoptotic cells in the human endometrium and placental villi: pitfalls in applying the TUNEL method. Arch Histol Cytol. 1995 58 : 185 90.
43. Domingo P, Matias-Guiu X, Pujol RM, Francia E, Lagarda E, Sambeat MA, Vazquez G. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS. 1999 13 : 2261 7.
44. Bursch W, Kleine L, Tenniswood M. The biochemistry of cell death by apoptosis. Biochem Cell Biol. 1990 68 : 1071 4.
45. Scruggs ER, Dirks Naylor AJ. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology. 2008 82 : 83 8.
46. Robinson B, Li Z, Nath A. Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglion cultures. J Neurovirol. 2007 13 : 160 7.
47. Cherry CL, Wesselingh SL. Nucleoside analogues and HIV: the combined cost to mitochondria. J Antimicrob Ther. 2003 51 : 1091 3.